Miscellaneous Flashcards
HLH, PNH, Gene therapy, novel approaches to Hb-opathies
Inherited causes of HLH (Haemophagocytic lymphohistiocytosis)?
- Familial (FHL)
- Immune deficiency syndromes (Eg Griscelli syndrome II)
-Acquired causes of HLH (Haemophagocytic lymphohistiocytosis)?
- Infections (eg leishmanial)
- Tumours (eg EBV associated lymphomas)
- Autoimmune disorders (eg SLE)
What are the clinical manifestations of HLH (Haemophagocytic lymphohistiocytosis)?
- Organ infiltration by T cells causing
- Haemophagocytosis (Macrophages engulfing red cells)
- Cytokine storm (By T cells and macrophages) - These effects result in: Fever, hepatosplenomegaly, lymphadenopathy, bone marrow failure (And many more)
-Pathogenesis of HLH (Haemophagocytic lymphohistiocytosis)?
Perforin is an essential protein in inducing apoptosis by CTLS or NKs
- Perforin failure
- CTLs cannot execute apoptosis, causing upregulation
- Homeostasis of cytotoxic lymphocyte responses becomes deregulated
- Clonal and polyclonal expansion of CTLs
Describe the pathophysiology of paroxysmal nocturnal haemoglobinuria (PNH)
- Deficiency in the glycosylphosphatidylinositol (GPI) anchor found on marrow stem cells
- This deficiency leads to a deficiency of GPI-linked proteins (Such as the membrane inhibitor of reactive lysis (MIRL) aka CD59)
- Red cells that descend from these stem cells also lack GPI and GPI-linked proteins, so become sensitive to lysis by complement. (especially MIRL/CD59, DAF/CD55)
Clinical features of paroxysmal nocturnal haemoglobinuria (PNH)?
- Chronic intravascular haemolysis
- Anaemia
- Nitric oxide depletion
- Thrombosis at unusual anatomical sites
- Bone marrow failure (BMF) and cytopenia
-Treatment of PNH-anaemia?
- Iron and folate supplements
- Blood transfusion
- Inhibition of haemolysis (Steroids or Complement inhibitors)
- Eculizumab: mAb: C5 inhibitor.
-Describe how gene therapy is being used in the treatment of SCD
- A psuedotyped lentivirus is used to inject wild-type Beta globin genes into HSCs, along with control sequences such as LCRs
- Lentiglobin BB305 has shown promising results
- Vector derived haemoglobin production improves clinical picture
Give an example of a novel approach for the treatment of sickle cell
Prevention of vaso-occlusion by P-selectin inhibitor Crizanlizumab
What are the main psychosocial problems in children with Sickle Cell Disease?
- Emotional challenge: Coming to terms with the illness
- Cognitive impairment leads to educational problems, where extra support may be required
- Adherence to treatment is also a problem
Explain the treatment of PNH
- Iron and folate supplements, Blood transfusion: to correct anaemia
- Eculizumab: mAb: C5 inhibitor.
- This mAb blocks the terminal complement pathway
- Membrane attack complex is not formed as a result
- This stops haemolysis mediated by complement
- Steroids can also be used to inhibit haemolysis
How is PNH diagnosed?
clinical features:
- Chronic intravascular haemolysis - Anaemia - Nitric oxide depletion - Thrombosis at unusual anatomical sites - Bone marrow failure (BMF) and cytopenia
-Diagnosis confirmed with flow cytometry: presence of CD55 and CD59